Reverse-contrast imaging and targeted radiation therapy of advanced pancreatic cancer models Journal Article


Authors: Thorek, D. L. J.; Kramer, R. M.; Chen, Q.; Jeong, J.; Lupu, M. E.; Lee, A. M.; Moynahan, M. E.; Lowery, M.; Ulmert, D.; Zanzonico, P.; Deasy, J. O.; Humm, J. L.; Russell, J.
Article Title: Reverse-contrast imaging and targeted radiation therapy of advanced pancreatic cancer models
Abstract: Purpose To evaluate the feasibility of delivering experimental radiation therapy to tumors in the mouse pancreas. Imaging and treatment were performed using combined CT (computed tomography)/orthovoltage treatment with a rotating gantry. Methods and Materials After intraperitoneal administration of radiopaque iodinated contrast, abdominal organ delineation was performed by x-ray CT. With this technique we delineated the pancreas and both orthotopic xenografts and genetically engineered disease. Computed tomographic imaging was validated by comparison with magnetic resonance imaging. Therapeutic radiation was delivered via a 1-cm diameter field. Selective x-ray radiation therapy of the noninvasively defined orthotopic mass was confirmed using γH2AX staining. Mice could tolerate a dose of 15 Gy when the field was centered on the pancreas tail, and treatment was delivered as a continuous 360° arc. This strategy was then used for radiation therapy planning for selective delivery of therapeutic x-ray radiation therapy to orthotopic tumors. Results Tumor growth delay after 15 Gy was monitored, using CT and ultrasound to determine the tumor volume at various times after treatment. Our strategy enables the use of clinical radiation oncology approaches to treat experimental tumors in the pancreas of small animals for the first time. We demonstrate that delivery of 15 Gy from a rotating gantry minimizes background healthy tissue damage and significantly retards tumor growth. Conclusions This advance permits evaluation of radiation planning and dosing parameters. Accurate noninvasive longitudinal imaging and monitoring of tumor progression and therapeutic response in preclinical models is now possible and can be expected to more effectively evaluate pancreatic cancer disease and therapeutic response. © 2015 Elsevier Inc. All rights reserved.
Keywords: controlled study; advanced cancer; nonhuman; cancer radiotherapy; pancreas cancer; radiation dose; nuclear magnetic resonance imaging; magnetic resonance imaging; mouse; computer assisted tomography; radiation; tumor volume; radiotherapy; animal experiment; animal model; tumor xenograft; oncology; ultrasound; computerized tomography; tomography; tumors; radiation oncology; dosimetry; fluorodeoxyglucose f 18; iohexol; experimental neoplasm; tumor growth; mammals; tissue injury; histone h2ax; nuclear magnetic resonance; diseases; pancreatic cancers; computed tomographic; ultrasonic applications; methods and materials; female; priority journal; article; genetically engineered mouse strain; ct (computed tomography); intraperitoneal administration; longitudinal imaging; radiation planning
Journal Title: International Journal of Radiation Oncology, Biology, Physics
Volume: 93
Issue: 2
ISSN: 0360-3016
Publisher: Elsevier Inc.  
Date Published: 2015-10-01
Start Page: 444
End Page: 453
Language: English
DOI: 10.1016/j.ijrobp.2015.06.001
PROVIDER: scopus
PMCID: PMC4575601
PUBMED: 26238952
DOI/URL:
Notes: Export Date: 2 October 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mary Ellen Moynahan
    105 Moynahan
  2. Maeve Aine Lowery
    133 Lowery
  3. Hans David Staffan Ulmert
    52 Ulmert
  4. John Laurence Humm
    433 Humm
  5. Pat B Zanzonico
    355 Zanzonico
  6. James Russell
    41 Russell
  7. Joseph Owen Deasy
    524 Deasy
  8. Mihaela E Lupu
    10 Lupu
  9. Jeho Jeong
    37 Jeong
  10. Robin Marie Kramer
    3 Kramer
  11. Alycia Marie Lee
    2 Lee
  12. Qing Chen
    19 Chen